3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neutropenia
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
Filgrastim
9
Cytarabine
7
Etoposide
5
Cefepime
4
Peripheral Blood Stem Cell Transplantation
3
Mitoxantrone
3
Levofloxacin
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Ciprofloxacin
3
Caspofungin
3
pegfilgrastim
2
liposomal amphotericin B
2
Thioguanine
2
Radiotherapy
2
Methotrexate
2
Meropenem
2
Itraconazole
2
Cyclophosphamide
2
Ceftazidime
2
Amsacrine
2
Amoxicillin-Potassium Clavulanate Combination
2
sargramostim
1
posaconazole
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
flt3 ligand protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Antiviral Agents
×
Other hematologic neoplasm
×
Clear all
NCT01821456
2013-04-01
CoCoNut
University Hospital of Cologne
Recruiting
100,000 enrolled